Pharmafile Logo

Peter Impey

- PMLiVE

AbbVie and Genmab’s blood cancer therapy granted FDA accelerated approval

Approximately 150,000 new cases of DLBCL are diagnosed globally each year

- PMLiVE

UK Biobank study to review human ageing over time moves into second stage

Over 60,000 volunteers to have second whole-body scans for imaging research study

- PMLiVE

Researchers at ICR London discover new nutrient source for cancer growth

Study reveals new findings of dietary changes within pancreatic cancer cells

Steph’s Story

Associate Medical Writer, Steph talks about her experiences with Generalised Anxiety Disorder and Panic Attacks

Mednet

Mario’s Story

Senior Designer, Mario talks about struggling with Generalised Anxiety Disorder, Social Anxiety Disorder resulting in mild OCD

Mednet

- PMLiVE

Our Work With Mind

In celebration of Mental Health Awareness Week 2023, we're sharing some of our recent work with Mind.

Mednet

- PMLiVE

AstraZeneca’s heart failure treatment recommended by NICE for expanded use

More than 550,000 patients have a confirmed heart failure diagnosis in England alone

- PMLiVE

MSD and Eisai’s combination therapy recommended by NICE for advanced endometrial cancer

More than 9,700 people are diagnosed with womb cancer each year in the UK

- PMLiVE

AbbVie’s Rinvoq recommended by NICE for Crohn’s disease

It is estimated that over 155,000 adults are living with the condition in the UK

- PMLiVE

Dermavant’s Vtama cream shows promise in phase 3 atopic dermatitis trial

The inflammatory skin disease affects over 26 million people in the US alone

OPEN Health_Drive, Discover, Dive

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

OPEN Health

- PMLiVE

Roche reports positive results for drug for relapsing forms of MS

The neurological disease affects approximately 2.8 million people worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links